224 related articles for article (PubMed ID: 21085060)
1. Long-term follow-up of 23 operational tolerant liver transplant recipients.
Tryphonopoulos P; Ruiz P; Weppler D; Nishida S; Levi DM; Moon J; Tekin A; Velez M; Neuman DR; Island E; Selvaggi G; Tzakis AG
Transplantation; 2010 Dec; 90(12):1556-61. PubMed ID: 21085060
[TBL] [Abstract][Full Text] [Related]
2. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
[TBL] [Abstract][Full Text] [Related]
4. Operational tolerance: past lessons and future prospects.
Levitsky J
Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of immunosuppression withdrawal after liver transplantation.
Girlanda R; Rela M; Williams R; O'Grady JG; Heaton ND
Transplant Proc; 2005 May; 37(4):1708-9. PubMed ID: 15919439
[TBL] [Abstract][Full Text] [Related]
6. Primary immunosuppression regimen of rapid steroid withdrawal after living related liver transplantation: a single-center experience.
Toyoki Y; Hakamada K; Narumi S; Totsuka E; Nara M; Ono H; Ishizawa Y; Sasaki M
Transplant Proc; 2004 Oct; 36(8):2279-81. PubMed ID: 15561218
[TBL] [Abstract][Full Text] [Related]
7. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
Dresske B; Haendschke F; Lenz P; Ungefroren H; Jenisch S; Exner B; El Mokhtari NE; Lu T; Zavazava N; Faendrich F
Transplantation; 2006 Jun; 81(11):1549-57. PubMed ID: 16770244
[TBL] [Abstract][Full Text] [Related]
8. Weaning of immunosuppression in liver transplant recipients.
Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
[TBL] [Abstract][Full Text] [Related]
9. What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation?
Pons JA; Revilla Nuin B; Ramírez P; Baroja Mazo A; Martínez Alarcón L; Robles R; Sánchez Bueno F; Rios A; Cascales Campos P; Parrilla P
Transplant Proc; 2012; 44(6):1530-2. PubMed ID: 22841204
[TBL] [Abstract][Full Text] [Related]
10. Tolerance and latent cellular rejection in long-term liver transplant recipients.
Wong T; Nouri-Aria KT; Devlin J; Portmann B; Williams R
Hepatology; 1998 Aug; 28(2):443-9. PubMed ID: 9696010
[TBL] [Abstract][Full Text] [Related]
11. Hot-topic debate on tolerance: immunosuppression withdrawal.
Sánchez-Fueyo A
Liver Transpl; 2011 Nov; 17 Suppl 3():S69-73. PubMed ID: 21850680
[TBL] [Abstract][Full Text] [Related]
12. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance.
de la Garza RG; Sarobe P; Merino J; Lasarte JJ; D'Avola D; Belsue V; Delgado JA; Silva L; Iñarrairaegui M; Sangro B; Sola JJ; Pardo F; Quiroga J; Herrero JI
Liver Transpl; 2013 Sep; 19(9):937-44. PubMed ID: 23784747
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after complete immunosuppression withdrawal in liver transplant recipients: rejection-free graft tolerance or late acute rejection?
Yoshida EM; Chung SW
Can J Gastroenterol; 1998 Sep; 12(6):387-9. PubMed ID: 9867428
[No Abstract] [Full Text] [Related]
14. Operational tolerance in clinical liver transplantation: emerging developments.
Tisone G; Orlando G; Angelico M
Transpl Immunol; 2007 Feb; 17(2):108-13. PubMed ID: 17306741
[TBL] [Abstract][Full Text] [Related]
15. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
16. Correlation of donor leukocyte chimerism with pulmonary allograft survival after immunosuppressive drug withdrawal in a porcine model.
Kruse B; Thissen S; Warnecke G; Avsar M; Gottlieb J; Hohlfeld JM; Karstens JH; Kaever V; Länger F; Pabst B; Ungefroren H; Haverich A; Strüber M
Transplantation; 2009 May; 87(10):1468-77. PubMed ID: 19461483
[TBL] [Abstract][Full Text] [Related]
17. Identification of tolerant recipients following liver transplantation.
Sánchez-Fueyo A
Int Immunopharmacol; 2010 Dec; 10(12):1501-4. PubMed ID: 20601182
[TBL] [Abstract][Full Text] [Related]
18. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance.
Banff Working Group on Liver Allograft Pathology
Liver Transpl; 2012 Oct; 18(10):1154-70. PubMed ID: 22645090
[TBL] [Abstract][Full Text] [Related]
19. Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies.
Girnita A; Mazariegos GV; Castellaneta A; Reyes J; Bentlejewski C; Thomson AW; Zeevi A
Hum Immunol; 2010 Mar; 71(3):274-6. PubMed ID: 20006667
[TBL] [Abstract][Full Text] [Related]
20. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
